RAAD HADDAD

Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism PHILADELPHIA, PA NPI 1962817635

General Payments — all program years on this page

$4,320.42

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 212
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $680.29 across 23 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $680.2923

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $65.604
2020 $623.5444
2021 $1,175.1169
2022 $1,267.2851
2023 $508.6021
2024 $680.2923

Records — PY2024 (23)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1094033101 Alexion Pharmaceuticals, Inc. $17.86 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096823383 Novo Nordisk Inc $26.81 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097073837 Novo Nordisk Inc $30.57 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097459914 Novo Nordisk Inc $23.03 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097602620 Novo Nordisk Inc $23.90 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097721378 Novo Nordisk Inc $19.04 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103859417 ABBVIE INC. $26.14 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103859419 ABBVIE INC. $23.38 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115691928 Amgen Inc. $20.93 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115691934 Amgen Inc. $25.41 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115691942 Amgen Inc. $27.17 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116804924 Insulet Corporation $27.26 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117775766 Corcept Therapeutics $88.08 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117776036 Corcept Therapeutics $108.68 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126847606 CeQur Corporation $27.57 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135305629 Lilly USA, LLC $24.37 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135323269 Lilly USA, LLC $24.69 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138715498 Tolmar, Inc. $15.84 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139872803 SANOFI-AVENTIS U.S. LLC $19.97 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149954084 Amphastar Pharmaceuticals, Inc. $15.45 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149954090 Amphastar Pharmaceuticals, Inc. $17.32 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149954097 Amphastar Pharmaceuticals, Inc. $23.82 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150846543 Neurocrine Biosciences, Inc. $23.00 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.